# FDA Inspection 1106106 - Blueprint Medicines Corporation - September 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/blueprint-medicines-corporation/0e627f0a-de53-4839-9e02-7b87afb74e3a
Source feed: FDA_Inspections

> FDA Inspection 1106106 for Blueprint Medicines Corporation on September 05, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106106
- Company Name: Blueprint Medicines Corporation
- Inspection Date: 2019-09-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1193294 - 2022-11-18](https://www.keypedia.com/records/fda_inspections/blueprint-medicines-corporation/890900c0-5c24-4df1-bb26-69cea0ecd78d)
- [FDA Inspection 1142661 - 2021-05-05](https://www.keypedia.com/records/fda_inspections/blueprint-medicines-corporation/0604b49a-e1d4-48ed-816f-debd5760fe4a)

Company: https://www.keypedia.com/companies/blueprint-medicines-corporation/92f765e6-81ff-46de-8cb1-dee7e91213fa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c